These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26796902)

  • 21. Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland.
    Moore T; Kennedy J; McCarthy S
    Int J Pharm Pract; 2014 Oct; 22(5):327-34. PubMed ID: 24433551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative Community Pharmacy Practice Models in North Carolina.
    Hemberg N; Huggins D; Michaels N; Moose J
    N C Med J; 2017; 78(3):198-201. PubMed ID: 28576962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separation of prescribing and dispensing in Malaysia: a summary of arguments.
    Shafie AA; Hassali MA; Azhar S; See OG
    Res Social Adm Pharm; 2012; 8(3):258-62. PubMed ID: 21824823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacist-led interventions for the management of medication misuse and abuse: A systematic review.
    Baum L; Badejo G; Chaboyer K; Leong C
    J Am Pharm Assoc (2003); 2017; 57(3):297-298. PubMed ID: 28268072
    [No Abstract]   [Full Text] [Related]  

  • 28. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community pharmacists preventing hospital readmissions.
    Clay PG
    J Am Pharm Assoc (2003); 2014; 54(2):208. PubMed ID: 24632935
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Health Policy; 2010 Jan; 94(1):68-75. PubMed ID: 19762106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' expectations of the role of the community pharmacist: Development and testing of a conceptual model.
    Sabater-Galindo M; Ruiz de Maya S; Benrimoj SI; Gastelurrutia MA; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(2):313-320. PubMed ID: 27185270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy practice around the world.
    Lutz EM; Rovers J; Mattingly J; Reed BN
    J Am Pharm Assoc (2003); 2009; 49(1):4-11. PubMed ID: 19196590
    [No Abstract]   [Full Text] [Related]  

  • 34. Community Pharmacists as Partners in Reducing Suicide Risk.
    Mospan CM; Gillette C; McKee J; Daniel SS
    J Am Board Fam Med; 2019; 32(6):763-767. PubMed ID: 31704742
    [No Abstract]   [Full Text] [Related]  

  • 35. What is keeping us busy in the Pharmacy?
    Bouvy ML
    Int J Pharm Pract; 2012 Aug; 20(4):207-8. PubMed ID: 22775516
    [No Abstract]   [Full Text] [Related]  

  • 36. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taking the fork in the road...and changing the world!
    Canaday BR
    J Am Pharm Assoc (2003); 2006; 46(5):546-8. PubMed ID: 17036639
    [No Abstract]   [Full Text] [Related]  

  • 38. A needs assessment of community pharmacists for pharmacist specialization in Canada.
    Jorgenson D; Penm J; MacKinnon N; Smith J
    Int J Pharm Pract; 2017 Apr; 25(2):159-167. PubMed ID: 27488476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes.
    American Pharmacists Association
    J Am Pharm Assoc (2003); 2012; 52(1):25-33. PubMed ID: 22173068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs, sex...and alcohol? Extending the community pharmacist's public health role.
    Watson MC; Sheridan J
    Int J Pharm Pract; 2011 Aug; 19(4):217-8. PubMed ID: 21733008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.